Auckland biopharma startup Helico has closed a $2.1 million seed investment round that was led by Icehouse Ventures, and included Custos Privatstiftung, the family office of Austrian billionaire Wolfgang Leitner and existing investor David Ross.
Leitner, whose wealth was valued at US$1.76
Want to read more? It's easy.
Choose your best value subscription option
Get instant access to this article now as part of our FREE two week trial.
Get two weeks free access to NBR’s Premium Online Subscription, which includes full access to all of NBR’s great content on any device.
